Co-Diagnostics completes studies for FDA flu and RSV test submission

July 1, 2026 9:01 AM

Co-Diagnostics, Inc. (Nasdaq: CODX) announced it has completed clinical and analytical performance studies for its PCR-based Flu A/B and RSV ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found